2-(1H-Indol-3-yl)-N-(5-methylisoxazol-3-yl)-2-oxoacetamide

Catalog No. :
ACACXB907
CAS No. :
893783-88-5
Molecular Formula :
C14H11N3O3
Molecular Weight :
269.26

IUPAC Name:2-(1H-indol-3-yl)-N-(5-methylisoxazol-3-yl)-2-oxoacetamide

2-(1H-Indol-3-yl)-N-(5-methylisoxazol-3-yl)-2-oxoacetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg95%$125.00Login to see priceInquiryInquiry
10mg95%$152.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(1H-Indol-3-yl)-N-(5-methylisoxazol-3-yl)-2-oxoacetamide
IUPAC Name2-(1H-indol-3-yl)-N-(5-methylisoxazol-3-yl)-2-oxoacetamide
Molecular FormulaC14H11N3O3
Molecular Weight269.26
SMILESO=C(NC1=NOC(C)=C1)C(C2=CNC3=C2C=CC=C3)=O
InChI KeyZBLHLLGKMABYSB-UHFFFAOYSA-N
Synonym2-(1H-indol-3-yl)-N-(5-methyl-1,2-oxazol-3-yl)-2-oxoacetamide;2-(1H-Indol-3-yl)-N-(5-methylisoxazol-3-yl)-2-oxoacetamide;1H-Indole-3-acetamide, N-(5-methyl-3-isoxazolyl)-α-oxo-
CAS No.893783-88-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACACXB907 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOULY350 route compound structure diagram
    ACOULY3501072-67-9 In Stock
  2. Plus
  3. ACWQBG348 route compound structure diagram
    ACWQBG3481477-49-2 In Stock
  4. Then
  5. ACACXB907 route product structure diagram
    ACACXB907893783-88-5
Inquiry

2. ACACXB907 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOULY350 route compound structure diagram
    ACOULY3501072-67-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACACXB907 route product structure diagram
    ACACXB907893783-88-5
Inquiry

Comments (0)